Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
American Journal of Obstetrics and Gynecology|January 25, 2025
Racial and ethnic enrollment disparities in clinical trials leading to Food and Drug Administration approvals for gynecologic malignanciesGabriel Levin, Bradley J Monk, Bhavana Pothuri, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 31, 2023
The promise of combining CDK4/6 inhibition with hormonal therapy in the first-line treatment setting for metastatic or recurrent endometrial adenocarcinomaIsabelle Ray-Coquard, Bradley J Monk, Domenica Lorusso, et al.
Gynecologic Oncology Reports|December 15, 2020
Clinical trials, adaptability and the COVID-19 pandemicRamez N Eskander, Bhavana Pothuri, Leslie Randall, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 6, 2026
Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partnersRobert L Coleman, Isabelle Ray-Coquard, Thomas J Herzog, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2012
A phase II, randomized, placebo-controlled study of vismodegib as maintenance therapy in patients with ovarian cancer in second or third complete remissionStanley B Kaye, Louis Fehrenbacher, Robert Holloway, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 18, 2024
Risk factors for major complications following pelvic exenteration: A NSQIP studyGabriel Levin, Brian Slomovitz, Jason D Wright, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 7, 2023
Mismatch repair deficiency, next-generation sequencing-based microsatellite instability, and tumor mutational burden as predictive biomarkers for immune checkpoint inhibitor effectiveness in frontline treatment of advanced stage endometrial cancerBreana L Hill, Ryon P Graf, Kunal Shah, et al.
Pageof 5